Ferring and PharmaBiome Enter Into a New Microbiome R&D Collaboration and Exclusive Licensing Agreement

Contributed by: Business Wire

Logo

Tags

Health

General Health

Research

Pharmaceutical

Science

Biotechnology

PharmaBiome

More Like This

Human Biome Announces Prediction of first-in class, Biosynthetic Microbiome Against Silent Pandemic of Antibiotic-Resistant Bacteria and Doses First Patients in Contextual FMT Study to validate it

PR Newswire associated0

Sequential and AMILI Secure Prestigious $1.8M UK-Singapore Collaborative R&D Project to Advance Gut-Skin Microbiome Science

The Biocodex Group Strengthens Its Position in Microbiota, With the Signature of a Licensing Agreement With My Health, a Belgian Biotech Company Specializing in Microbiota Solutions

Business Wire associated0

Microba Delivers Landmark IBD Results & Signs Major Gastro Partner

PR Newswire associated0

Crown Laboratories, Inc. and BIOJUVE® Celebrate World Microbiome Day 2024

MRM Health Initiates Clinical Research in Parkinson’s Disease

71.4% of MetaXplore™ reports from 4,616 patients identified actionable results

Microba Announces Landmark GI Study Results From Over 4,600 Patients

Live Biotherapeutics at a Crossroad: Novotech White Paper Outlines Opportunities and Early-Stage Challenges